| Certification: | ISO, FDA, Hahal, Food Manufacturing License, Business Licens |
|---|---|
| Assay Method: | HPLC, UV |
| Application Form: | Tablet, Capsule |
| Application: | Food, Health Care Products, Medicine |
| State: | Powder |
| Extract Source: | Sophora Japonica L. |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier | Product Name | Fructus Sophorae Extract |
| Botanical Name | Sophora japonica L. |
| Part Used | Fruit |
| Appearance | Light Yellow to White powder |
| Specification | 4:1 10:1 Straight Powder 30% 50% 98% Genistein |
| Storage Period | 24 Months |
| Package | 1kg/bag 25kg/drum |
| Storage Conditions | Store in cool and dry places. Keep away from strong light and heat. |
| Description Fructus sophorae is the dried ripe fruit of Styphnolobium japonicum (L.). It has traditionally been used for its anti-inflammatory properties, cooling blood and stopping bleeding (using blood cooling hemostatics) in Korean and Chinese medicine Health Benefits Heart health Genistein is thought to benefit heart health through maintaining normal arterial elasticity and hence helping prevent hypertension. More specifically, genistein may help prevent cardiac hypertrophy. This condition involves abnormal enlargement and thickening of the heart muscle often a result of high blood pressure (hypertension) or valvular disease. A recent study (1) has shown genistein is able to reduce cardiac hypertrophy in vivo. The authors suggest the underlying mechanisms of genistein activity may be associated with blocking the JNK1/2 signalling pathways. Additionally, a new paper (2) suggests that genistein can provide protection against the risk of ischaemic stroke. The authors suggest the mechanism is through the reduction of oxidative stress, promotion of growth-factor signalling, and immune suppression in endothelial, glial and neuronal cells. Cancer Research suggests that genistein intake can reduce levels of 8-Epiprostaglandin and 5 Hydroxymethyl 2-desoxyuridine in the blood. These markers are associated with a reduced risk of the onset of prostate cancer (3). It is believed genistein can reduce oxidative DNA damage, which lead to elevated levels of these markers. Further, genistein intake is associated with raised levels of blood enzymes that are able to help clear toxic metabolites e.g. Glutathion-S-transferase, Quinone reductase and UDP-glucuronosyl transferase. In addition, it is suggested genistein may have a beneficial effect in providing protection against the onset of breast cancer. Genistein alone is able to induce apoptosis (cell death) in some breast cancer cells, but this can be enhanced if equol, a bioactive metabolite of daidzein (another isoflavone), is present (4). Bone health Genistein is believed to be beneficial for bone health though maintenance of bone mineral density. Specifically, it is thought to downregulate the resorption marker desoxypyridinoline while upregulating the bone synthesis markers IGF-I protein and bone alkaline phosphatase. Estrogen deficiency is a major contributor to the development of osteoporosis in older women. Genistein is able to bind to estrogen receptors. However, to date, the results of human intervention studies have been mixed and further work is required (5). Brain health A recent pre-clinical study (6) has demonstrated that genistein may play a neuroprotective role in Alzheimer's disease through regulating CAMK4 (calcium/calmodulin dependent protein kinase IV) and thus reducing the hyperphosphorylation of tau protein. It is the excessive phosphorylation of tau protein that causes production of neurofibrillary tangles, which is one of the main pathological characteristics of Alzheimer's disease. |
|
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}